EEU - pharmacokinetic equation??? [Power / Sample Size]

posted by mittyri – Russia, 2017-12-29 14:11 (930 d 03:22 ago) – Posting: # 18126
Views: 25,744

Hi Yura,

» So I understand: imagine the power analysis and draw a conclusion (at low power) that since bioequivalence is established, a posteriori power rating does not affect the findings of the study
Yep. Once again: to be lucky is not a crime :-D
and vice versa: if the post-hoc power is -> 100%, you're a hero even if the study was overpowered de facto (i.e. CI [0.98-1.03]).

» More interesting question: the pharmacokinetic equation and its analysis ... :confused:
Good question! Next question!
Seems like they are interested in PK model which is not permitted. No clue so far :-|

Kind regards,

Complete thread:

 Admin contact
20,862 posts in 4,361 threads, 1,451 registered users;
online 36 (2 registered, 34 guests [including 9 identified bots]).
Forum time: 18:34 CEST (Europe/Vienna)

The interpretation of facts in a certain way
stimulates other scientists’ thoughts.    Róbert Bárány

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz